We've found
184,457
clinical trials
Endocrinology Clinical Trial
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus (SLE) Clinical Trial
Prospective Study of Rapamycin for the Treatment of SLE
Status: Enrolling,
Phase
II
Updated: 12/12/2012
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Islet After Kidney Transplant for Type 1 Diabetes
Status: Enrolling,
Phase
I, II
Updated: 1/6/2014
Click here to add this to my saved trials
Healthy Clinical Trial
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast
Status: Enrolling
Updated: 7/22/2009
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy
Status: Enrolling
Updated: 12/9/2011
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Longitudinal Evaluation of Women Undergoing Pelvic Exenteration for Treatment of Gynecologic Malignancy
Status: Enrolling,
Phase
Updated: 2/28/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
OVATIO CRT and SITUS OTW LV Lead Post Approval Study
Status: Enrolling
Updated: 3/1/2012
Click here to add this to my saved trials
Heart Failure Clinical Trial
OVATIO CRT and SITUS OTW LV Lead Post Approval Study
Status: Enrolling
Updated: 3/1/2012
Click here to add this to my saved trials
Heart Failure Clinical Trial
OVATIO CRT and SITUS OTW LV Lead Post Approval Study
Status: Enrolling
Updated: 3/1/2012
Click here to add this to my saved trials
Heart Failure Clinical Trial
OVATIO CRT and SITUS OTW LV Lead Post Approval Study
Status: Enrolling
Updated: 3/1/2012
Click here to add this to my saved trials
Heart Failure Clinical Trial
OVATIO CRT and SITUS OTW LV Lead Post Approval Study
Status: Enrolling
Updated: 3/1/2012
Click here to add this to my saved trials
Heart Failure Clinical Trial
OVATIO CRT and SITUS OTW LV Lead Post Approval Study
Status: Enrolling
Updated: 3/1/2012
Click here to add this to my saved trials
Human Immuno Deficiency (HIV) Infection Clinical Trial
A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Human Immuno Deficiency (HIV) Infection Clinical Trial
A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Multi-Tracer PET Assessment of Primary Brain Tumors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Rapid Eye Movement Sleep Behavior Disorder Clinical Trial
RBD Longitudinal as Prognostic for PD
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Phenytoin Toxicity Clinical Trial
Phenytoin and Multidose Activated Charcoal
Status: Enrolling
Updated: 1/14/2009
Click here to add this to my saved trials
HIV-1 Clinical Trial
A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1
Status: Enrolling
Updated: 3/7/2013
Click here to add this to my saved trials
Acute Myelogenous Leukemia Clinical Trial
Targeted, Dose-Escalated Intravenous Busulfan and Bolus Etoposide as Preparative Therapy for Patients With Acute Myeloid Leukemia Undergoing Autologous Stem Cell Transplantation
Status: Enrolling
Updated: 10/2/2012
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology Clinical Trial
Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP)
Status: Enrolling,
Phase
IV
Updated: 1/21/2009
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Psychiatry / Psychology Clinical Trial
Intraoperative Blood Pressure and Cognitive Performance
Status: Enrolling
Updated: 6/13/2013
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer
Status: Enrolling
Updated: 1/5/2011
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Endothelial Function and Vein Graft Remodeling
Status: Enrolling
Updated: 4/1/2016
Click here to add this to my saved trials
Growth Hormone Deficiency Clinical Trial
Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
Status: Enrolling,
Phase
II
Updated: 5/6/2009
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Methionine PET/CT Studies In Patients With Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hodgkin Lymphoma Clinical Trial
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hodgkin Lymphoma Clinical Trial
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Genetic Susceptibility to Bladder Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cancer Screening and Prevention Program for High Risk Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety of Acidform Lubricant in HIV-Uninfected Women
Status: Enrolling
Updated: 10/26/2012
Click here to add this to my saved trials
Advanced Cancers Clinical Trial
Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol
Status: Enrolling
Updated: 1/19/2018
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Neurology, Otolaryngology, Other, Reproductive Clinical Trial
Screening Protocol for Genetic Diseases of Allergic Inflammation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Injury Clinical Trial
Prospective Evaluation of Blunt Renal Injury in Children
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer
Status: Enrolling,
Phase
II, III
Updated: 11/18/2013
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer
Status: Enrolling,
Phase
II, III
Updated: 11/18/2013
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
We've found
184,457
clinical trials
Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Systemic Lupus Erythematosus (SLE) Clinical Trial
Updated: 12/12/2012
Prospective Study of Rapamycin for the Treatment of SLE
Status: Enrolling,
Phase
II
Updated: 12/12/2012
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Updated: 1/6/2014
Islet After Kidney Transplant for Type 1 Diabetes
Status: Enrolling,
Phase
I, II
Updated: 1/6/2014
Click here to add this to my saved trials
Healthy Clinical Trial
Updated: 6/13/2017
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Updated: 6/13/2017
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Updated: 6/13/2017
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Updated: 6/13/2017
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Updated: 6/13/2017
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Updated: 6/13/2017
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Updated: 6/13/2017
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Updated: 6/13/2017
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Updated: 6/13/2017
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Updated: 6/13/2017
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Healthy Clinical Trial
Updated: 6/13/2017
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Status: Enrolling,
Phase
III
Updated: 6/13/2017
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 7/22/2009
Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast
Status: Enrolling
Updated: 7/22/2009
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Updated: 12/9/2011
Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy
Status: Enrolling
Updated: 12/9/2011
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Updated: 2/28/2018
Longitudinal Evaluation of Women Undergoing Pelvic Exenteration for Treatment of Gynecologic Malignancy
Status: Enrolling,
Phase
Updated: 2/28/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 3/1/2012
OVATIO CRT and SITUS OTW LV Lead Post Approval Study
Status: Enrolling
Updated: 3/1/2012
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 3/1/2012
OVATIO CRT and SITUS OTW LV Lead Post Approval Study
Status: Enrolling
Updated: 3/1/2012
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 3/1/2012
OVATIO CRT and SITUS OTW LV Lead Post Approval Study
Status: Enrolling
Updated: 3/1/2012
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 3/1/2012
OVATIO CRT and SITUS OTW LV Lead Post Approval Study
Status: Enrolling
Updated: 3/1/2012
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 3/1/2012
OVATIO CRT and SITUS OTW LV Lead Post Approval Study
Status: Enrolling
Updated: 3/1/2012
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 3/1/2012
OVATIO CRT and SITUS OTW LV Lead Post Approval Study
Status: Enrolling
Updated: 3/1/2012
Click here to add this to my saved trials
Human Immuno Deficiency (HIV) Infection Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Human Immuno Deficiency (HIV) Infection Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Multi-Tracer PET Assessment of Primary Brain Tumors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Rapid Eye Movement Sleep Behavior Disorder Clinical Trial
Updated: 12/31/1969
RBD Longitudinal as Prognostic for PD
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Phenytoin Toxicity Clinical Trial
Updated: 1/14/2009
Phenytoin and Multidose Activated Charcoal
Status: Enrolling
Updated: 1/14/2009
Click here to add this to my saved trials
HIV-1 Clinical Trial
Updated: 3/7/2013
A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1
Status: Enrolling
Updated: 3/7/2013
Click here to add this to my saved trials
Acute Myelogenous Leukemia Clinical Trial
Updated: 10/2/2012
Targeted, Dose-Escalated Intravenous Busulfan and Bolus Etoposide as Preparative Therapy for Patients With Acute Myeloid Leukemia Undergoing Autologous Stem Cell Transplantation
Status: Enrolling
Updated: 10/2/2012
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology Clinical Trial
Updated: 1/21/2009
Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP)
Status: Enrolling,
Phase
IV
Updated: 1/21/2009
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Psychiatry / Psychology Clinical Trial
Updated: 6/13/2013
Intraoperative Blood Pressure and Cognitive Performance
Status: Enrolling
Updated: 6/13/2013
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 1/5/2011
Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer
Status: Enrolling
Updated: 1/5/2011
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 4/1/2016
Endothelial Function and Vein Graft Remodeling
Status: Enrolling
Updated: 4/1/2016
Click here to add this to my saved trials
Growth Hormone Deficiency Clinical Trial
Updated: 5/6/2009
Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
Status: Enrolling,
Phase
II
Updated: 5/6/2009
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Methionine PET/CT Studies In Patients With Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hodgkin Lymphoma Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hodgkin Lymphoma Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Updated: 12/31/1969
Genetic Susceptibility to Bladder Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cancer Screening and Prevention Program for High Risk Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 10/26/2012
Safety of Acidform Lubricant in HIV-Uninfected Women
Status: Enrolling
Updated: 10/26/2012
Click here to add this to my saved trials
Advanced Cancers Clinical Trial
Updated: 1/19/2018
Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol
Status: Enrolling
Updated: 1/19/2018
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Neurology, Otolaryngology, Other, Reproductive Clinical Trial
Updated: 12/31/1969
Screening Protocol for Genetic Diseases of Allergic Inflammation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Injury Clinical Trial
Updated: 12/31/1969
Prospective Evaluation of Blunt Renal Injury in Children
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Updated: 11/18/2013
NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer
Status: Enrolling,
Phase
II, III
Updated: 11/18/2013
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Updated: 11/18/2013
NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer
Status: Enrolling,
Phase
II, III
Updated: 11/18/2013
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials